Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TH-302 in combination with chemotherapy for advanced solid tumors
NCT00743379Phase 2Completed
- Sponsor
- Threshold Pharmaceuticals
- Start
- Aug 2008
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of evofosfamide in pancreatic cancer (PC), prostate cancer (PCa), non-small cell lung cancer (NSCLC), sponsored by Threshold Pharmaceuticals. Started Aug 2008; status: completed.
02
Drugs
evofosfamide
03
Conditions
pancreatic cancer (PC)prostate cancer (PCa)non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00743379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743379.